Literature DB >> 8114819

Molecular cloning and serological characterization of a Brugia malayi pepsin inhibitor homolog.

S Dissanayake1, M Xu, C Nkenfou, W F Piessens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8114819     DOI： 10.1016/0166-6851(93)90191-y

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  14 in total

1.  Immune responses to recombinant Brugia malayi pepsin inhibitor homolog (Bm-33) in patients with human lymphatic filariaisis.

Authors:  N S A Krushna; C Shiny; G Manokaran; S Elango; S Babu; R B Narayanan
Journal:  Parasitol Res       Date:  2010-10-07       Impact factor: 2.289

2.  Multiplex bead assay for serum samples from children in Haiti enrolled in a drug study for the treatment of lymphatic filariasis.

Authors:  Delynn M Moss; Jeffrey W Priest; Alexis Boyd; Tiffany Weinkopff; Zuzana Kucerova; Michael J Beach; Patrick J Lammie
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

3.  Identification of abundantly expressed novel and conserved genes from the infective larval stage of Toxocara canis by an expressed sequence tag strategy.

Authors:  K K Tetteh; A Loukas; C Tripp; R M Maizels
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  The abundant larval transcript-1 and -2 genes of Brugia malayi encode stage-specific candidate vaccine antigens for filariasis.

Authors:  W F Gregory; A K Atmadja; J E Allen; R M Maizels
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

5.  Recombinant Brugia malayi pepsin inhibitor (rBm33) induced monocyte function and absence of apoptotic cell death: an in vitro study.

Authors:  Kirthika Sreenivas; Kamalakannan Vijayan; Subash Babu; Rangarajan Badri Narayanan
Journal:  Microb Pathog       Date:  2012-03-30       Impact factor: 3.738

6.  Multiplex Serology for Measurement of IgG Antibodies Against Eleven Infectious Diseases in a National Serosurvey: Haiti 2014-2015.

Authors:  YuYen Chan; Diana Martin; Kimberly E Mace; Samuel E Jean; Gillian Stresman; Chris Drakeley; Michelle A Chang; Jean F Lemoine; Venkatachalam Udhayakumar; Patrick J Lammie; Jeffrey W Priest; Eric William Rogier
Journal:  Front Public Health       Date:  2022-06-09

7.  An aspartyl protease inhibitor orthologue expressed by Parelaphostrongylus tenuis is immunogenic in an atypical host.

Authors:  Michael S Duffy; Nancy MacAfee; Michael D B Burt; Judith A Appleton
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

8.  Evaluation of the recombinant antigens Wb14 and WbT for the capture antibody diagnosis of lymphatic filariasis.

Authors:  André Filipe Pastor; Abraham Rocha; Klécia de Melo Cassemiro; Marli Tenório; Paula Melo; Maria Rosângela Grilis; Maressa Rhuama; Antonio Mauro Rezende; Osvaldo Pompilio de Melo Neto; Ernesto Marques; Rafael Dhalia
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-03-26       Impact factor: 2.743

9.  A structural biology approach to understand human lymphatic filarial infection.

Authors:  Raghavendra Sashi Krishna Nagampalli; Krishnasamy Gunasekaran; Rangarajan Badri Narayanan; Angela Peters; Rajagopalan Bhaskaran
Journal:  PLoS Negl Trop Dis       Date:  2014-02-06

10.  Integration of Multiplex Bead Assays for Parasitic Diseases into a National, Population-Based Serosurvey of Women 15-39 Years of Age in Cambodia.

Authors:  Jeffrey W Priest; M Harley Jenks; Delynn M Moss; Bunsoth Mao; Sokhal Buth; Kathleen Wannemuehler; Sann Chan Soeung; Naomi W Lucchi; Venkatachalam Udhayakumar; Christopher J Gregory; Rekol Huy; Sinuon Muth; Patrick J Lammie
Journal:  PLoS Negl Trop Dis       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.